Kineta, Inc. is a Seattle-based privately held biotechnology company specializing in clinical advancement of novel drug candidates derived from leading edge scientific research. The world-class scientists are pioneers in developing life-changing classes of new drugs designed to be more effective and safer than current medicines. Kineta seeks to improve the lives of millions of people suffering from autoimmune and viral diseases and from severe pain. The Kineta progressive business model focuses on targeting unmet medical needs and rapid achievement of important clinical milestones. For more information on Kineta, Inc. visit, http://www.kinetabio.com.
ACT’s purpose is to advance and speed the development of pediatric therapies. ACT brings together a top 5 U.S. pediatric hospital and research institution with a nationally recognized biotechnology company to combine forces and expertise to meet the specific challenges of pediatric therapy development. ACT will initially work with KPI's most advanced clinical drug candidate for autoimmunity and attempt to advance treatments for children’s autoimmune diseases. Ultimately, ACT intends to address a broader set of pediatric illnesses. As part of ACT and in support of its mission, KPI, the Foundation, and SCRI will jointly pursue funding opportunities and then develop drug candidates to meet the needs of its pediatric patient populations. We believe this is a first-of-its-kind alliance between for-profit and non-profit organizations aimed at specifically solving the therapeutic problems of children. For more information, visit: www.childrenstherapeutics.org/
Chimera Biotec GmbH is a technology provider and specialty clinical research organization offering ligand-binding assay development and sample analysis based on the Imperacer® (Immuno-PCR) technology. Imperacer® combines the unmet specificity of ELISA-type ligand-binding assay technology with the most sensitive detection system known in molecular biology; a real-time PCR read-out. Chimera Biotec provides Imperacer® method development and validation services as well as downstream bioanalytical sample testing support to meet most challenging demands in immunoanalytics. Imperacer® services are conducted under strict quality regime and bioanalytical sample testing is available for all regulatory demands. Chimera Biotec is privately held and based in Germany. For more details about Chimera Biotec, visit http://www.chimera-biotec.com.
CoMotion is the UW’s collaborative innovation hub. A national leader in university technology transfer, CoMotion offers expertise in models for distribution, in managing software and digital assets, in IP planning and protection, and in licenses and negotiation. By promoting entrepreneurial thinking, innovation mindsets, creative problem-solving, and experiential, team-based project learning, CoMotion delivers the tools and connections the UW community needs to accelerate the impact of UW innovations and to grow local and global innovation ecosystems. For more information, visit: comotion.uw.edu.
Established in 1995 and headquartered in Ontario, Canada, Life Chemicals Inc. is a chemical contract research organization focused on delivery of innovative products and services for early stage small molecule drug discovery. The Company offers a unique diverse set of 400,000 organic compounds synthesized in house, along with a broad range of medicinal and computational chemistry services including hit-to-lead and lead optimization, as well as design and synthesis of targeted libraries for various target classes. With almost 20 years of successful business history, more than 1,000 customers worldwide and subsidiaries in USA, Germany and Ukraine, Life Chemicals Inc. is one of the internationally recognized contract research organizations that provides high quality services for life science industries. For more information about Life Chemicals Inc. please go to http://www.lifechemicals.com.
MME is an industry leader in developing value driven pricing, reimbursement and market access strategies for biopharmaceutical clients worldwide. MME was established in 2001 and has over 35 professionals located in Oxford, MS; Montclair, NJ; Milan and the UK. MME's client base includes large and emerging bio/pharmaceutical firms and has conducted hundreds of pricing assignments in over 50 countries. For more information on MME, visit http://www.m2econ.com
MPI Research, with global headquarters in Mattawan, Michigan, provides efficacy and safety evaluation, bioanalytical, and analytical testing, and early clinical services and solutions to the biopharmaceutical, medical device, animal health, and chemical industries. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer, better products to the world. For more information on MPI Research, visit http://www.mpiresearch.com.
UW Medicineʼs mission is to improve the health of the public by advancing medical knowledge, providing patient care, and training the next generation of health professionals. Our system includes Harborview Medical Center, Northwest Hospital & Medical Center, Valley Medical Center, UW Medical Center, UW Neighborhood Clinics, UW Physicians, UW School of Medicine and Airlift Northwest. For more information, visit: uwmedicine.org.